RetroSense Therapeutics Receives $6,000,000 Series A Funding Round

  • Feed Type
  • Date
    1/10/2015
  • Company Name
    RetroSense Therapeutics
  • Mailing Address
    330 East Liberty Street LL Ann Arbor, MI 48104 USA
  • Company Description
    Led by a team of seasoned veterans, RetroSense Therapeutics was founded in 2009 to develop a novel gene therapy approach to vision restoration.
  • Website
    http://www.retro-sense.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company intends to use the funds to enable completion of preclinical studies needed to support an Investigational New Drug (IND) filing with the U.S. Food and Drug Administration for its lead compound, RST-001 for the treatment of Retinitis Pigmentosa, a cause of vision loss and blindness.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy